.STUDY HIGHLIGHT.06 August 2024.
A sizable randomized controlled test with cisgender ladies highlights the problems of fidelity to an everyday oral preexposure prophylaxis routine and also illustrates that twice-yearly shot of lenacapavir can sustain efficient HIV avoidance levels over 6 months.